Labcorp Holdings Inc. (LH) Fair Value 2026

LH · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.7 /10

32 fundamental signals · 10 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-08-27, Labcorp Holdings Inc. (LH) trades at $336.54, versus a $201.30 median fair value across its 10 active models — 40.2% below the current price. QOC: 7.7/10. Value Trap Risk: 12/100 (SAFE). 10/13 models active. Within that set, the Bayesian DCF component alone returns $249.33.

Key Facts

Ticker
LH
Price
$336.54
Quality Score
7.7/10
Value Trap Risk
12/100
Models Active
10/13
Last Updated
Strength: 10 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Labcorp Holdings Inc. (LH) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Labcorp Holdings Inc. (LH) appears overvalued as of : the median of 10 independent fair value estimates is $201.30, 40.2% below the current price of $336.54. Estimates range from $93.19 to $639.42. LH scores 7.7/10 on fundamental quality and 12/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. LH’s -40.2% gap is wider than that market norm, and the Diagnostics & Research sector median is -54.1%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Labcorp Holdings Inc. Stock in 2026? →

What Fair Value Does Each Model Give LH?

10 Intrinsic Value Models vs. Current Price ($336.54)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $249.33 -25.9%
Intrinsic · High Conviction
 $151.28 -55.0%
Ensemble · Low Conviction
 $214.80 -36.2%
Intrinsic · High Conviction
 $93.19 -72.3%
Unlock the Full Matrix

Access 6 additional models including Markov DDM, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is LH's Fair Value Range?

Spread across 10 independent models · $93.19 to $639.42

CirclFi's 10 active models place Labcorp Holdings Inc. (LH) between $93.19 and $639.42 per share, a spread of 271% of the median. The median of that range — $201.30 — is the fair value CirclFi publishes for LH, against a current price of $336.54.

Low · EROICHigh · Regime Cross
$93.19median $201.30$639.42
Where the range comes from
Most bearish modelEROIC Spread$93.19
Most bullish modelRegime Cross-Sectional$639.42
Model agreement3 bullish · 7 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for LH. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on LH, not a CirclFi price target. How each model works →

What Is Labcorp Holdings Inc. (LH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Labcorp Holdings Inc.'s intrinsic value is estimated at a median fair value of $201.30. Trading at $336.54, the stock is approaching fair value or slight overvaluation (implied return of -40.2%), as 7 of 10 models suggest limited further upside. Notably, Regime Cross sees the most upside at +90.0% (fair value: $639.42), while EROIC is the most conservative at -72.3% ($93.19). The spread between these extremes — +162.3% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About LH?

10 of 13 models are currently active for LH. Of these, 3 models suggest upside while 7 models suggest overvaluation. Taken together, their median fair value for LH is $201.30 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $249.33 on its own, implying -25.9% downside from the current price. See which stocks rank higher →

How Does LH Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, LH ranks #15 by Quality of Company score. CirclFi's QOC score of 7.7/10 evaluates 32 fundamental signals. A score of 7.7 indicates above-average quality.

Labcorp Holdings Inc.'s positioning within the Diagnostics & Research segment means that clinical trial success rate plays an outsized role in fundamental analysis. The sector's unique characteristics — including late-stage pipeline catalysts — shape both the opportunity set and risk profile.

Is LH a Value Trap?

CirclFi's Value Trap algorithm assigns LH a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Labcorp Holdings Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Labcorp Holdings Inc. earns a quality score of 7.7/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +162.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every LH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across LH's 10 active models, average confidence is 57%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Labcorp Holdings Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

10 related Diagnostics & Research stocks with 13-model coverage

WATWaters CorporationQOC 7.7LDDDLongduoduo Company LimitedQOC 7.5BLLNBillionToOne, Inc.QOC 7.7NTRANatera, Inc.QOC 7.5TMOThermo Fisher Scientific Inc.QOC 7.8RVTYRevvity, Inc.QOC 7.4RDNTRadNet, Inc.QOC 6.7ADVBAdvanced Biomed Inc.QOC 5.0MEDPMedpace Holdings, Inc.QOC 9.3IDXXIDEXX Laboratories, Inc.QOC 9.5

Read investment analysis: WAT · LDDD · BLLN · NTRA · TMO · RVTY · RDNT · ADVB · MEDP · IDXX

Which Other Stocks Have a Similar Quality Score to LH?

7 companies across all industries closest to LH’s Quality of Company score of 7.7/10.

RHIRobert Half Inc.QOC 7.7APTVAptiv PLCQOC 7.7ASRVAmeriServ Financial, Inc.QOC 7.7TRVGtrivago N.V.QOC 7.7JCSEJE Cleantech Holdings LimitedQOC 7.7GBTGGlobal Business Travel Group, Inc.QOC 7.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: RHI · APTV · ASRV · TRVG · JCSE · GBTG · NVDA

What Else Do Investors Ask About Labcorp Holdings Inc.’s Valuation?

What is Labcorp Holdings Inc.'s intrinsic value in 2026?

CirclFi puts Labcorp Holdings Inc. (LH)'s intrinsic value at $201.30 — the median of 10 independent model estimates as of 2026-08-27, ranging from $93.19 to $639.42. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $249.33 on its own. The Quality of Company score is 7.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is LH overvalued or undervalued right now?

At $336.54, 3 of 10 active models suggest LH may be undervalued, while 7 indicate potential overvaluation. The median of all 10 fair value estimates is $201.30, 40.2% below the current price of $336.54 — a consensus view that LH is overvalued. The assessment depends on which methodology best fits Labcorp Holdings Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 7.7 mean for LH?

Labcorp Holdings Inc.'s QOC of 7.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on LH?

CirclFi analyzes LH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on LH?

Of the 10 models currently active on LH, Regime Cross-Sectional is the most bullish at $639.42 per share, and EROIC Spread is the most bearish at $93.19. CirclFi's published fair value for LH is the median of that range, $201.30, not either extreme. The gap between the two ends equals 271% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is LH a value trap in 2026?

Labcorp Holdings Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Labcorp Holdings Inc. (LH) has a median fair value of $201.30 — 40.2% below the current price of $336.54 — as of 2026-08-27.” Source: circlfi.com/stock/LH/ · Methodology
Primary sources for this LH valuation
  • Financial statements: Labcorp Holdings Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000920148) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for LH as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on LH.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for LH Unlock All 10 — $39/mo